Nilotinib hard capsules 50, 150 and 200 mg product-specific bioequivalence guidance
EMEA-000802-PIP01-09
Herbal medicinal product: Boldi folium, Peumus boldus Molina, C: ongoing call for scientific data
Human medicines European public assessment report (EPAR): Repaglinide Teva, repaglinide, Date of authorisation: 28/06/2009, Revision: 10, Status: Authorised
Executive Steering Group on Shortages and Safety of Medicinal Products
Human medicines European public assessment report (EPAR): Aprovel, irbesartan, Date of authorisation: 26/08/1997, Revision: 50, Status: Authorised
Consolidated 3-year work plan for the Emergency Task Force (ETF)
Human medicines European public assessment report (EPAR): Kinpeygo, budesonide, Date of authorisation: 15/07/2022, Revision: 11, Status: Authorised
Minutes of the COMP meeting 3-5 December 2024
Agenda of the CVMP meeting 11-13 February 2025